SOCIETY FOR NEURO-ONCOLOGY Annual Report 2022
soc-neuro-onc.org
This Annual Report covers the SNO 2022 fiscal year, from July 1, 2021 through June 31, 2022.
soc-neuro-onc.org
From the President Tracy Batchelor
Dear Colleagues,
We had a successful in person annual meeting in Tampa this year. We received a record number of scientific abstract submissions, and we had a record number of meeting attendees. And, for the first time in SNO history, we have surpassed 3,000 society members. We celebrate that the majority of our elected SNO leaders are now women and that all 5 officers elected to the SNO Board of Directors this year were women. To further advance the principles of diversity, equity, and inclusion SNO has engaged a consultant to work with the leadership to develop a strategic plan for our society. We will incorporate these principles into the fabric of all SNO programs and activities. In closing, I would like to acknowledge the dedication of our members who are on the frontlines of clinical care, teaching, and research. It is thanks to their volunteerism, resilience, creativity, and collaborative spirit that I am confident SNO will continue to flourish well into the future.
Despite the lingering effects of the pandemic, I am pleased to share with you that the state of our Society is strong. I thank my predecessor, Gelareh Zadeh, who ably guided SNO during her term as President under challenging circumstances. I also thank the SNO Executive Committee –Vice President Daphne Haas-Kogan, Secretary Treasurer Jill Barnholtz-Sloane, and Executive Director Chas Haynes – as well as the SNO board of directors, journal editors, committee chairs, and track leaders, who collectively provided outstanding leadership in advancing our mission. And a special word of thanks to the SNO administrative staff for their remarkable dedication and tireless efforts on behalf of our members. We launched several important new initiatives this year. The new, weekly SNO Digest provides timely and important information on SNO activities to over 18,000 members and other neuro-oncology colleagues in 52 different countries. In recognition of the fact that most brain tumor patients receive their care in the community, a new Community Neuro- Oncology Committee was established to foster collaborative relationships with community providers of neuro-oncology care. In keeping with our efforts to invest in the next generation of neuro-oncology professionals, a new Career Development and Training Committee was launched to provide resources, support, and mentorship to students, residents, fellows, and mid-career members.
Sincerely,
2 Society for Neuro-Oncology
soc-neuro-onc.org
Our Mission
The Society for Neuro-Oncology exists to advance multi-disciplinary brain tumor research, education, and collaboration to drive discovery and improve patient care.
- 2022 Society for Neuro-Oncology Annual Meeting
From the Executive Director Chas Haynes
I am so proud of the members of the SNO administrative team, who -- in the face of unique adversity and uncertainty -- have remained mission- focused and dedicated to delivering outstanding education, resources and new initiatives to our multidisciplinary stakeholders. The shared experiences and learnings of the pandemic have in many ways made the Society stronger and more dynamic, especially in terms of the delivery of electronic education. And, as we return to in-person meetings, we are now able to incorporate this knowledge into our core educational offerings. I am immensely grateful to immediate past SNO President, Gelareh Zadeh, and current President, Tracy Batchelor, for their skillful diplomacy and leadership during these difficult times. Thanks to their efforts, SNO remains uniquely positioned to support our international membership as we build community, increase diversity, and generate data- driven education and innovation.
Dear Society Members and Friends of SNO,
As you will read in the pages that follow, SNO continues its remarkable trajectory of growth and remains committed to adding value to its members in North America and around the world.
Sincerely,
Society for Neuro-Oncology 3
soc-neuro-onc.org
The Neuro-Oncology Family of Journals
The Neuro-Oncology family of journals continues to provide exceptional value to the field.
SNO’s flagship journal, Neuro-Oncology is committed to publishing the highest quality research to enhance the scientific understanding of CNS tumors. Published in partnership with the European Association of Neuro- Oncology, Neuro-Oncology Practice continues to perform well, and is an important educational resource for those on the frontlines of clinical care. Also published in partnership with EANO, Neuro-Oncology Advances is the premier Open Access title in the field and ensures that SNO is at the forefront of academic publishing. The Society for Neuro-Oncology is pleased to share that the most recent Journal Citation Reports™ provides that the Impact Factor for Neuro-Oncology , has risen to 13.029 (up from 12.30).
Given the relatively narrow editorial focus of Neuro- Oncology as a subspecialty publication, these are remarkable statistics, and the Society is grateful to Kenneth Aldape who served as Editor-in-Chief of Neuro-Oncology during the period that the new citation report covers.
Citation Impact – A Quality Metric
13.029
12.3
10.091 10.247
9.384
2017
2018
2019
2020
2021
New Editorial Leadership for Neuro-Oncology This year SNO announced the appointment of Susan Chang as the new Editor-in-Chief of Neuro-Oncology. Dr. Chang succeeds Dr. Kenneth Aldape. Dr. Chang is a Professor of Neurological Surgery at the University of California, San Francisco Weill Institute for Neurosciences, and co-leader of the Neuro-Oncology Program at the Helen Diller Family Comprehensive Cancer Center. No stranger to editorial leadership, she formerly served as the Founding Editor-in-Chief of Neuro-Oncology ’s sister title, Neuro-Oncology Practice . Her outstanding record of academic excellence, past service to the Society, and familiarity with the neuro-oncology publishing enterprise, makes her the ideal candidate to advance the educational mission of the journal. Commenting on her appointment, Dr. Chang said: “I am humbled and honored to be named to this role. I stand on the shoulders of giants – former Editors Drs. Darell Bigner, W.K. Alfred Yung, Patrick Wen, and Kenneth Aldape – and I am eager to build on their outstanding efforts to take the journal to new heights. I look forward to working with the leaders of ASNO, EANO and SNO, the Editorial Board, and all neuro-oncology stakeholders, as we build community, increase diversity, and generate data-driven education and innovation to our readers around the world.”
4 Society for Neuro-Oncology
soc-neuro-onc.org
Neuro-Oncology is currently ranked 8 th out of all 212 in Clinical Neurology titles and 21 st out of all 245 Oncology titles.
Neuro-Oncology Editor-in-Chief Susan Chang Neuro-Oncology Practice Editor-in-Chief Martin Taphoorn Neuro-Oncology Advances
Editor-in-Chief Gelareh Zadeh
Society for Neuro-Oncology 5
soc-neuro-onc.org
New Initatives
Improving Diversity, Equity & Inclusion DEI is imperative for SNO. It is not only the right thing to do, but the smart thing to do – for our field, and for our patients. SNO has recently engaged a consultant to help the Society craft a longitudinal plan for incorporating the principles of DEI into all our programs and events.
Engaging the Community Practitioner
We recognize that most brain tumor patients are seen in the community setting. This year, SNO embarked on a new initiative dedicated to ensuring patients obtain the best possible treatment wherever they receive their care.
Expanding E-Learning Opportunities Officially launched in April, the Neuro-Oncology Academy contains over 60 unique presentations in 14 modules covering all neuro-oncology subspecialties.
More Education on Pediatric Neuro-Oncology
SNO continues to support and invest in pediatric education. A Pediatric Tumor Board has been launched, and planning is already underway for the 2023 Pediatric Neuro-Oncology Research Conference. SNO also provided administrative support for the 2022 International Symposium on Pediatric Neuro-Oncology event in Hamburg.
6 Society for Neuro-Oncology
soc-neuro-onc.org
Improving Member Communications
This year SNO launched the SNO Digest. In this weekly e-newsletter, we aim to provide the latest news related to the neuro-oncology field by highlighting publications from the Neuro-Oncology family of journals, key clinical trials, podcast features, information on upcoming meetings and SNO seminars, updates from the SNO committees, featured job openings and opportunities for
advocacy. This Digest also seeks to become a staple resource of information that brings together our affiliated fields and societies. In addition, special “meeting editions” of the SNO Digest will be published twice per-day during the course of the Annual Meeting.
Investing the Future New initiatives were launched this year to attract the best and the brightest young professionals to our field, and to provide the resources, mentorship and support throughout the trajectory of our members’ careers.
Working with Sister Societies SNO was proud to partner with the American Society of Clinical Oncology (ASCO) on the Conference on CNS Clinical Trials and Brain Metastases held August 12-13, 2022, in Toronto, Canada. Also during this fiscal year, SNO co- published practice guidelines with ASCO, the American Society for Radiation Oncology, and the European Association of Neuro-Oncology.
Global Education The Society for Neuro-Oncology in Sub-
Saharan Africa (SNOSSA) held its 2022 Annual Conference July 22-24, 2022, in Accra, Ghana. SNO looks forward to collaborating with the leadership of SNOSSA on future events. After a hiatus due to COVID, international outreach travel scholarships for the SNO Annual Meeting were reintroduced for the 2022 Annual Meeting.
Society for Neuro-Oncology 7
soc-neuro-onc.org
2021 Annual Meeting Boston, Massachusetts
Chairs
Women in Neuro-Oncology Awards
CNS Rare Disease Award Yohei Miyake
Scientific Chairs Albert Kim Priscilla Brastianos Farshad Nassiri
WiN Mentorship Award Amy Heimberger
CNS Rare Disease Award Marta Penas-Prado
WiN Mid-Career Exemplary Physician Award Priscilla Brastianos WiN Basic/Translational Science Research Award Defne Bayik
CNS Metastases Award Philipp Karschnia
Education Day I – Biomarkers Daniel Orringer Houtan Noushmehr Susan Short
CNS Metastases Award Christopher Alvarez-Breckenridge
Education Day II - Multidisciplinary Practice
Neuroimaging Award Anahita Fathi Kazerooni
Maureen Daniels Sandra Johnston
WiN Clinical Research Award Emma Nicklin
Pathology Award Frederick S. Varn
Awards
Abstract Awards
Pediatric Basic Science Award Yuan Pan
Lifetime Achievement Award Eric Bouffet
Basic Science Award David D. Tran
Mary Marit Swenson Award for Pediatric DMG/DIPG Robert Siddaway
Victor Levin Award & Lecture Timothy Cloughesy
Basic Science Award Dena Panovska
Abhijit Guha Award & Lecture Amy Heimberger (presented at the AANS/CNS Section on Tumors Conference) Jan Esenwein Public Service Award Nicole Willmarth
Basic Science Award Varun Venkataramani
Radiation Award Roman O. Kowalchuk, MD
Clinical Trials Award Patrick Y. Wen
Survivorship Award Heather Leeper
Clinical Trials E. Antonio Chiocca
Surgery Award Clark C. Chen
Clinical Trials John H. Sampson
Andrew Parsa Young Investigator Award Gilles Berger
2021 Annual Meeting
Abstracts 913
Unique Countries 30
Attendees (in-person) 1640
Exhibitors 45
8 Society for Neuro-Oncology
soc-neuro-onc.org
2022 Annual Meeting Tampa Bay, Florida
Chairs
Women in Neuro-Oncology Awards
CNS Rare Disease/Neurogenetic Tumor Syndromes Award Scott R. Plotkin
Scientific Chairs Priscilla Brastianos Shawn Hervey-Jumper Albert H. Kim
WiN Mentorship Award Ute Bartels
Healthcare Equity Award Joshua A. Budhu
WiN Mid-Career Exemplary Physician Award Lakshmi Nayak WiN Basic/Translational Science Research Award Zulekha A. Qadeer
Track Leader Farshad Nassiri
Neuro-Imaging Award Maciej Harat
Education Day I – Cancer Neuroscience Michelle Monje Humsa Venkatesh Varun Venkataramani
Pathology Award Simona Migliozzi
Radiation Award Justin Wang
WiN Clinical Research Award Anahita Fathi Kazerooni
Education Day II – CNS Cancer Survivorship Milan Chheda Mariella Filbin Jennie Taylor Jeffrey Wefel
Marit Mary Swenson Award for Pediatric DMG/DIPG Charles A. Day
Abstract Awards
Basic Science Award Takahide Nejo
Pediatric Basic Science Award Karen D. Wright
Basic Science Award Giuliana V. Zarrella
Awards
Surgery Award Philipp Karschnia
Lifetime Achievement Award Stuart A. Grossman
Basic Science Award Martha A. Cady
Survivorship Award Kelcie D. Willis
Victor Levin Award & Lecture Michelle Monje
Clinical Trials Award David Peereboom David Reardon
Andrew Parsa Young Investigator Award Julie Bennett
2022 At Glance The Annual Meeting enjoyed robust participation, from both North American and Internationally. Jan Esenwein Public Service Award Adam Hayden Clinical Trials Award Capucine Baldini CNS Metastases Award Lu Sun Abhijit Guha Award & Lecture Manish K. Aghi
2022 Annual Meeting
Abstracts 1153
Unique Countries 48
Attendees (in-person) 2570
Exhibitors 57
Society for Neuro-Oncology 9
soc-neuro-onc.org
Support and Gifts
2021 and 2022 Annual Meetings
Supporters
AstraZeneca Azurity Pharmaceuticals Bayer Biocept Brain Tumor Network Brainlab BTG Specialty Candel Therapeutics/ Advantagene Inc. Caris Life Science
Seagen Siteman Cancer Center SonALAsense Stemline, A Menarini Group Company
Platinum Level American Brain Tumor Association AstraZeneca Chimerix National Brain Tumor Society Novocure The Sontag Foundation
The Brain Tumor Charity The Sontag Foundation University of Florida Neuroscience Varian Zap Surgical
Benefactor Level Bristol-Myers Squibb Kazia Therapeutics Orbus Therapeutics
CERN Foundation at NBTS Children’s Tumor Foundation Chimerix ClearPoint Neuro, Inc. Cortech.ai Day One Biopharmaceutical Designs for Vision, Inc. Elekta End Brain Cancer Intiative FieldCure GT Medical Technologies Head For The Cure Foundation Illumina, Inc. Imaging Biometrics International Brain Tumor Alliance Ivy Brain Tumor Center Kiyatec, Inc.
2021 SNO Pediatric Conference
Supporters
Supporter Level Bayer Day One Biopharmaceutical DNATrix Illumina, Inc. Seagen SonALAsense Contributor Level 10X Genomics Beigene Denovo Biotherapeutics Eisai EndBrainCancer Intitative Monteris Medical Nationwide Children’s Hospital Northwest Biotherapeutics Plus Therapeutics Pyramid Bioscience SDP Oncology
Presenting Supporter Pediatric Brain Tumor Foundation
Platinum Level Supporters American Brain Tumor Association Bayer National Brain Tumor Society The Sontag Foundation
Silver Level Supporter AstraZeneca Chimerix, Inc. Orbus Therapeutics
Medidata Medtronic Merck Mirati Therapeutics
2021 ASCO/SNO Conference on Clinical Trials
Moffitt Cancer Center Monteris Medical, Inc. National Brain Tumor Society National Cancer Institute NICO Corporation Northwest Biotherapeutics Novocure Orbus Therapeutics, Inc. Plus Therapeutics Pyramid Bioscience Renishaw Neuro Solutions Limited
Grant Support Novocure
2021 Conference on Brain Metastases
General Level Supporter Azurity Pharmaceuticals
Supporters
Exhibitors 10x Genomics Accuray Alexion Pharmaceuticals American Brain Tumor Association
Platinum Level Supporters American Brain Tumor Association Chimerix, Inc. National Brain Tumor Society
Reveal Surgical Rosman Search
15 Society for Neuro-Oncology 10 Society for Neuro-Oncology
soc-neuro-onc.org
Novocure Seagen The Sontag Foundation Silver Level Supporters Illumina Orbus Therapeutics Bronze Level Supporters Kazia Therapeutics Monteris Medical
GT Medical Technologies Illumina, Inc. Kazia Therapeutics Monteris Medical, Inc. National Brain Tumor Society Novocure Medical Affairs Orbus Therapeutics, Inc. Seagen The Sontag Innovation Fund and the Brain Tumor Network Varian Zap Surgical
Ali K Choucair in Memory of Ab Guha
Victor Levin for the Victor Levin Founders Fund
AmazonSmile Foundation
2022 Clinical Trials and Brain Metastases Conferences
Maximal Safe Brain Tumor Resection Conference
Supporters
Supporters
Platinum Level Supporters American Brain Tumor Association Bristol-Myers Squibb National Brain Tumor Society The Sontag Innovation Fund and the Brain Tumor Network
Platinum Level Supporters NX Development Corporation Omniscient Stryker Bronze Level Supporters GT Medical Technologies Focused Ultrasound Foundation Hemerion
Gold Level Supporter Novocure Medical Affairs
Silver Level Supporters Daiichi Sankyo Orbus Therapeutics Bronze Level Supporters Illumina Kazia Therapeutics
Gifts
The Blackbaud Giving Fund on Behalf of Price Waterhouse Coopers LLP and its Donors
Monteris Medical Plus Therapeutics Seagen Varian
YourCause on Behalf of Bosch and its Donors
Exhibitors American Brain Tumor Association Biocept Bristol-Myers Squibb Daiichi Sankyo
Childhood Brain Tumor Foundation for International Outreach
Society for Neuro-Oncology 11
soc-neuro-onc.org
Financial Highlights Fiscal Year Ended June 30, 2021
The following financial highlights are prepared by management of the Society for Neuro- Oncology for the fiscal year ended June 30, 2021 and are intended for this Annual Report, only. The financial information is in the process of being audited by an independent accounting firm. Once the audit is complete, the financial statements and Independent Auditor’s Report will be posted at www.soc-neuro-onc.org.
Statement of Financial Position highlights, as of June 30, 2021:
Cash and cash equivalents
$ 2,302,000
Investments
$ 3,678,000
Contributions receivable
$ 509,000
Endowment assets
$ 418,000
Total assets
$ 6,907,000
Liabilities
$ 298,000
Net assets
$ 6,609,000
Total liabilities & net assets
$ 6,907,000
Statement of Activities highlights, for the fiscal year ended June 30, 2021:
Total revenues and other support
$ 3,912,000
Total program and supporting service expenses
$ 2,154,000
Change in net assets
$ 1,758,000
12 Society for Neuro-Oncology
soc-neuro-onc.org
Financial Highlights Fiscal Year Ended June 30, 2022
The following financial highlights are prepared by management of the Society for NeuroOncology for the fiscal year ended June 30, 2022 and are intended for this Annual Report, only. The financial information is in the process of being audited by an independent accounting firm. Once the audit is complete, the financial statements and Independent Auditor’s Report will be posted at www.soc-neuro-onc.org.
Statement of Financial Position highlights, as of June 30, 2022:
Cash and cash equivalents
$ 2,091,000
Investments
$ 3,121,000
Contributions receivable
$ 895,000
Endowment assets
$ 317,000
Total assets
$ 6,424,000
Liabilities
$ 305,000
Net assets
$ 6,119,000
Total liabilities & net assets
$ 6,424,000
Statement of Activities highlights, for the fiscal year ended June 30, 2022:
T otal revenues and other support
$ 3,869,000
Total program and supporting service expenses
$ 4,359,000
Change in net assets
$ (490,000)
Society for Neuro-Oncology 13
soc-neuro-onc.org
2022 Leadership
Guidelines Manmeet Ahluwalia, Maryam Fouladi, Tobias Walbert Membership Omar Arnaout, Oluwatosin Akintola, Julie Miller, Alissa Thomas
Officers
Basic Science Representative Joseph Costello
President Tracy Batchelor
Radiation Oncology Representative Jennifer Yu
Vice President Daphne Haas-Kogan
Foundation Board
Secretary-Treasurer Jill Barnholtz-Sloan
Public Policy Antonio Chiocca, Erik Sulman
Mitchel S. Berger, Susan Chang Antonio Chiocca, Victor A. Levin David Reardon
Executive Director (Ex Officio) Chas Haynes
Training & Career Development Jaishri Blakeley, Ashley Margol, Vinay Puduvalli, Shaan Raza Wellness Alvina Acquaye, Katy Peters, Shlomit Yust-Katz
Journal Editors-in-Chief
Board of Directors
Neuro-Oncology Susan Chang
Immediate Past President Gelareh Zadeh
Neuro-Oncology Practice Martin Taphoorn
Journal Editor-in-Chief (Ex Officio) Susan Chang
Women and Diversity Macarena de la Fuente, Jose McFaline Figueroa, Reena Thomas
Neuro-Oncology Advances Gelareh Zadeh
Allied Health Representative Susan Bell
Committee Chairs
Young Investigators Tab Cooney, Elizabeth Gerstner, Sam McBrayer
Neurology Representative Eudocia Q. Lee
Audit James Perry
Young Investigator Representative Gavin Dunn
Conference Chairs
Awards Priscilla Brastianos, Eva Galanis, Shawn Hervey-Jumper, Albert Kim, Gelareh Zadeh
Annual Meeting Priscilla Brastianos, Albert Kim, Shawn Hervey-Jumper
Neurosurgery Representative Linda Bi
Bylaws Nick Butowski
Radiology Representative Benjamin Ellingson
Annual Meeting, Track Leader Farshad Nassiri
Communications Iyad Alnahhas, Linda Bi, Nicholas Gonzalez-Castro Community Neuro-Oncology Sajeel Chowdhary, Christine Lu-Emerson External Relations John de Groot, Erin Dunbar, Karisa Schreck
Pathology Representative Jason Huse
Annual Meeting, Survivorship Education Day Milan Chheda, Mariella Filbin, Jennie Taylor, Jeffrey Wefel Annual Meeting, Neuroscience Education Day Michelle Monje, Varun Venkataramani, Humsa Venkatesh
Pediatrics Representative Annie Huang
Medical Oncology Representative Erin Dunbar
15 Society for Neuro-Oncology 14 Society for Neuro-Oncology
soc-neuro-onc.org
Staff
Survivorship Heather Leeper, Susan Chang
J. Charles (Chas) Haynes Executive Director Shelley Pressley Director of Administration Ginger Vazquez Manager of Technology Integration Tara A. Mammoser Manager of Medical Education MeLesa Ritterhouse Manager of Neuro-Oncology Academy & CME Caroline K. Noor Manager of Member Services and Giving Kristina Knight Manager of Medical Education Megan Bell-Johnston Exhibits and Support Specialist Gabrielle Griffin Marketing and Communications Specialist
SNO/ASCO Conference on CNS Clinical Trials and Brain Metastases Priscilla Brastianos, Mustafa Khasraw
Track Chairs
Basic Science Joseph Costello, Frank Furnari, Annette Molinaro
Brain Metastases Alexandra Zimmer, Priya Kumthekar
Cancer Neurology Eudocia Lee, Maciej Mrugala
Clinical Trials Solmaz Sahebjam, Mustafa Khasraw
CNS Rare Disease Mark Gilbert, Terri Armstrong
Molecular Pathology Jason Huse, Sandro Santagata, Stephen Yip
Neurogenetic Tumor Syndromes Brigitte Widemann, Jaishri Blakeley
Neuroimaging Derek Johnston, Raymond Huang, Javier Villanueva-Meyer
Amelia Hutsell Administrative Specialist
Neurosurgery Ian Dunn, Isabella Germano, Lissa Baird
Pamela Newell Bookkeeper
Radiation Sciences Debra Yeboa, Jennifer Yu
Pediatrics Annie Huang, Robert Wechsler-Reya
Society for Neuro-Oncology 15
CONTACT US
SOCIETY FOR NEURO-ONCOLOGY PO Box 273296 Houston, TX 77277
tel 713.526.0269 fax 832.201.8129
soc-neuro-onc.org
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16Made with FlippingBook - Share PDF online